Quasi‑Migraine Headache

What is Quasi‑Migraine Headache?

A quasi‑migraine headache (sometimes called a “migraine‑type headache” or “migraine‑like headache”) is a painful headache that shares many features with classic migraine but does not meet all the formal diagnostic criteria for migraine. Patients often describe a moderate‑to‑severe, throbbing or pulsating pain that may be unilateral (one side of the head) or bilateral, and it can be accompanied by typical migraine accompaniments such as nausea, photophobia (light sensitivity), or phonophobia (sound sensitivity).

Because the presentation is “partial,” clinicians use the term “quasi‑migraine” to indicate that the headache is migraine‑like but may be triggered by other medical conditions, medication overuse, or lifestyle factors. Understanding the nuances helps providers pinpoint the underlying cause and select an appropriate treatment plan.

Common Causes

Quasi‑migraine headaches are not a disease in themselves; they are a symptom complex that can arise from many different conditions. Below are the most frequently encountered causes:

• Medication‑overuse headache (MOH): Frequent use of analgesics, triptans, or caffeine‑containing drugs can transform episodic migraine into a daily or near‑daily headache.
• Tension‑type headache with migraine features: When muscle tension co‑exists with vascular changes, the pain may mimic migraine.
• Hormonal fluctuations: Menstrual cycles, perimenopause, or hormonal therapy can produce migraine‑like attacks that don’t fulfill full criteria.
• Sinus disease or nasal polyps: Inflammation of the sinus cavities can cause throbbing pain and facial pressure that feels migraine‑like.
• Primary stabbing headache (ice‑pickle headache): Short, stabbing pains that can trigger a lingering migraine‑type head pain.
• Sleep disorders: Obstructive sleep apnea and chronic insomnia are linked to migraine‑type headaches that lack classic aura.
• Head trauma or concussion: Post‑concussion syndrome often includes migraine‑like headaches.
• Neurological conditions: Cervicogenic headache, occipital neuralgia, or even early multiple sclerosis can present with migraine‑like features.
• Metabolic disturbances: Hypoglycemia, hyponatremia, or severe dehydration can precipitate migraine‑type pain.
• Infections: Viral illnesses (e.g., influenza) or bacterial meningitis can start with a quasi‑migraine before other signs appear.

Associated Symptoms

Quasi‑migraine headaches frequently occur with the following accompanying features. Not every patient will have all of them, but the presence of several clues helps differentiate from other headache types.

• Nausea or vomiting – up to 70% of patients report an upset stomach.
• Photophobia – intolerance to bright light.
• Phonophobia – heightened sensitivity to sound.
• Visual disturbances – mild blurred vision or “seeing stars” without true aura.
• Neck stiffness or tenderness – especially when tension‑type factors are contributing.
• Fatigue or lethargy – can follow or precede the headache.
• Changes in appetite – cravings or aversions, often seen with hormonal triggers.
• Vertigo or dizziness – more common when inner‑ear or vestibular involvement is present.

When to See a Doctor

Most quasi‑migraine headaches can be managed with over‑the‑counter remedies and lifestyle changes. However, certain warning signs warrant prompt medical evaluation:

• Headache that is sudden and “worst ever” (thunderclap headache).
• Persistent pain lasting longer than 72 hours despite treatment.
• New onset after age 50 or a change in the pattern of longstanding headaches.
• Associated neurological deficits – weakness, numbness, speech problems, or vision loss.
• Fever, stiff neck, or rash (possible infection).
• Headache after head injury, even if mild.
• Worsening pain despite stopping over‑used medications (suggests medication‑overuse headache).

If any of these appear, schedule an appointment promptly or go to an emergency department.

Diagnosis

Diagnosing a quasi‑migraine involves a combination of patient history, physical examination, and sometimes targeted testing.

1. Detailed History

• Frequency, duration, and intensity of attacks (use a visual analog scale).
• Trigger identification – foods, stress, sleep patterns, hormonal changes.
• Medication usage – type, dose, and frequency.
• Associated symptoms listed above.
• Family history of migraine or other headache disorders.

2. Physical & Neurological Exam

• Assessment of cranial nerves, motor strength, sensation, and gait.
• Evaluation of neck range of motion and trigger points (muscle tenderness).
• Fundoscopic exam for papilledema if increased intracranial pressure is suspected.

3. Diagnostic Tests (when indicated)

• Imaging: MRI or CT scan if red‑flag symptoms exist or if a secondary cause (tumor, bleed) must be excluded.
• Blood work: CBC, electrolytes, fasting glucose, thyroid panel to rule out metabolic triggers.
• Sleep study: For suspected sleep‑apnea related headaches.
• Sinus X‑ray or CT: When sinus disease is a concern.

All diagnostic criteria are based on the International Classification of Headache Disorders, 3rd edition (ICHD‑3) and adapted for quasi‑migraine patterns.¹

Treatment Options

Management is individualized, targeting both the headache itself and any underlying trigger.

Acute (Abortive) Therapies

• Non‑prescription NSAIDs: Ibuprofen 400‑600 mg or naproxen 500 mg taken at headache onset.
• Acetaminophen: 1000 mg if NSAIDs are contraindicated.
• Triptans: Sumatriptan 50‑100 mg oral or 6 mg subcutaneous for patients with a confirmed migraine component.
• Anti‑emetics: Metoclopramide 10 mg IV/PO or prochlorperazine 5–10 mg for nausea.
• Combination analgesics: Excedrin (acetaminophen‑aspirin‑caffeine) can be effective but limited to <10 days/month to avoid MOH.

Preventive (Prophylactic) Therapies

• Beta‑blockers: Propranolol 40‑160 mg daily – especially helpful if stress‑related.
• Anticonvulsants: Topiramate 25‑100 mg nightly or valproic acid 500‑1000 mg daily.
• Antidepressants: Amitriptyline 10‑50 mg at bedtime for patients with comorbid tension‑type features.
• CGRP monoclonal antibodies: Erenumab, fremanezumab – considered for refractory cases.
• Botulinum toxin A: 155‑195 units injected across the head and neck for chronic daily or near‑daily headaches.

Addressing Underlying Causes

• Stop or taper overused medications under physician supervision.
• Treat sinus infection with appropriate antibiotics or nasal corticosteroids.
• Hormonal therapy adjustment (e.g., low‑dose estrogen patches) for menstrual‑related headaches.
• Weight loss, CPAP therapy, or sleep hygiene for obstructive sleep apnea.
• Cervical physiotherapy for neck‑related components.

Non‑pharmacologic Home Measures

• Cold or warm compress: Apply to the forehead or neck for 10‑15 minutes.
• Hydration: Aim for at least 2 L of water daily.
• Regular meals: Avoid fasting; include complex carbs and protein.
• Sleep schedule: 7‑9 hours of consistent sleep; limit screens before bed.
• Stress‑reduction techniques: Progressive muscle relaxation, meditation, yoga.
• Limit triggers: Reduce caffeine (<200 mg/day), avoid processed cheese, MSG, and alcohol.

Prevention Tips

Even when a definitive cause cannot be identified, many patients can lower the frequency and severity of quasi‑migraine headaches by adopting the following habits:

• Maintain a headache diary: Record date, time, intensity, foods, stressors, and medication use. Patterns become apparent over weeks.
• Exercise regularly: Moderate aerobic activity (30 min, 3‑5 times/week) reduces stress hormones.
• Ergonomic workspace: Adjust monitor height, use a supportive chair, and take micro‑breaks every hour.
• Limit screen brightness and use blue‑light filters: Helpful for photophobia.
• Stay up‑to‑date on vaccinations: Prevents infection‑related headaches.
• Screen medications: Discuss with your doctor any drugs that may exacerbate headaches (e.g., certain antihypertensives, oral contraceptives).

Emergency Warning Signs

---

Quasi‑migraine headaches sit at the intersection of classic migraine and secondary headache disorders. Recognizing patterns, addressing triggers, and collaborating with a healthcare provider can dramatically improve quality of life.

References

1. International Classification of Headache Disorders, 3rd edition (ICHD‑3). Headache Classification Committee of the International Headache Society. 2018.
2. Mayo Clinic. “Migraine.” Updated 2023. https://www.mayoclinic.org
3. Cleveland Clinic. “Medication Overuse Headache.” 2022. https://my.clevelandclinic.org
4. American Migraine Foundation. “Preventive Treatments for Migraine.” 2023.
5. National Institute of Neurological Disorders and Stroke (NINDS). “Headache.” 2022. https://www.ninds.nih.gov